Every living creature on Earth needs to protect itself from things that would do it harm. Bacteria are no different. And ...

The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 ...

Newly discovered weapons of bacterial self-defense take different approaches to achieving the same goal: preventing a virus from spreading through the bacterial population.

Since its discovery in 2011, CRISPR-Cas 9 has revolutionized medicine. One of the companies at the forefront of this ...

Treated with an individualized gene-editing therapy that corrects mutations directly on the genome, a patient shows ...

Those hoping the Court of Appeals for the Federal Circuit would finally resolve priority in the long-pending dispute between the University ...

Recent biotechnological innovations like genome — editing in crop breeding are seen as major achievements to address the challenges of food security and also to reduce the burden of agriculture to ...

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing ...

CRISPR-Cas: Pioneering Custom Red Blood Cells for Universal Compatibility. Blood type compatibility has always been a critical factor in medical treatments, particularly in blood ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

The CRISPR-Cas gene editing tool has shown promising potential in the field of blood compatibility, offering a solution to the challenges faced by patients with rare blood types and addressing chronic ...

Excision announces publication highlighting EBT-107 for treatment of chronic hepatitis B in bioRxiv: Watertown, Massachusetts Friday, May 16, 2025, 18:00 Hrs [IST] Excision BioThe ...